Literature DB >> 30738750

Trends and Updates on Cardiopulmonary Bypass Setup in Pediatric Cardiac Surgery.

Ravi Medikonda1, Chin Siang Ong2, Rajeev Wadia3, Dheeraj Goswami3, Jamie Schwartz3, Larry Wolff2, Narutoshi Hibino2, Luca Vricella2, Daniel Nyhan3, Viachaslau Barodka3, Jochen Steppan4.   

Abstract

Perfusion strategies for cardiopulmonary bypass have direct consequences on pediatric cardiac surgery outcomes. However, inconsistent study results and a lack of uniform evidence-based guidelines for pediatric cardiopulmonary bypass management have led to considerable variability in perfusion practices among, and even within, institutions. Important aspects of cardiopulmonary bypass that can be optimized to improve clinical outcomes of pediatric patients undergoing cardiac surgery include extracorporeal circuit components, priming solutions, and additives. This review summarizes the current literature on circuit components and priming solution composition with an emphasis on crystalloid, colloid, and blood-based primes, as well as mannitol, bicarbonate, and calcium.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  pediatric cardiac surgery; pediatric perfusion; perfusion

Mesh:

Substances:

Year:  2019        PMID: 30738750     DOI: 10.1053/j.jvca.2019.01.025

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  2 in total

1.  Effect of different cardioprotective methods on extracorporeal circulation in fetal sheep: a randomized controlled trial.

Authors:  Yi-Bo Yan; Shuo Shi; Qian-Biao Wu; Jin-Sheng Cai; Bin-Feng Lei
Journal:  J Cardiothorac Surg       Date:  2021-04-17       Impact factor: 1.637

2.  Effect of cardiopulmonary bypass reoxygenation on myocardial dysfunction following pediatric tetralogy of Fallot repair.

Authors:  Ji-Nong Yang; Xiao-Ming Zhang; Hong Liu; Lu-Yao Ma; Zhan-Jie Lu; Si-Qiang Zheng; Al-Wajih Hamzah; Yong-Feng Shao; Gao-Li Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-04-26       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.